SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-24-008534
Filing Date
2024-05-21
Accepted
2024-05-21 16:05:12
Documents
4
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20240521x6k.htm 6-K 19161
2 EX-1 tmb-20240521xex1.htm EX-1 671799
3 EX-2 tmb-20240521xex2.htm EX-2 119201
4 EX-3 tmb-20240521xex3.htm EX-3 171865
  Complete submission text file 0001558370-24-008534.txt   983127
Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40241 | Film No.: 24969303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)